1
Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa
Condition(s):Visceral LeishmaniasisLast Updated:February 29, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Visceral LeishmaniasisLast Updated:February 29, 2024Completed
Condition(s):Cutaneous Leishmaniasis, AmericanLast Updated:February 2, 2021Completed
Condition(s):Visceral LeishmaniasisLast Updated:January 21, 2016Completed
Condition(s):PKDL – Post-Kala-Azar Dermal LeishmanioidLast Updated:January 18, 2020Unknown status
Condition(s):Leishmaniasis, VisceralLast Updated:May 26, 2010Completed
Condition(s):Visceral LeishmaniasisLast Updated:February 11, 2010Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.